Phosphorus GABA Analogues as Potential Prodrugs

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Organic Synthesis

Background:

• Gamma-aminobutyric acid (GABA) is a primary inhibitory neurotransmitter in the central nervous system.
• Developing novel drug delivery systems is crucial for enhancing therapeutic efficacy and reducing side effects.
• Acid-labile carrier molecules offer potential for targeted drug release.

Purpose of the Study:

• To synthesize novel GABA analogues incorporated into Schiff bases.
• To evaluate the in vitro hydrolysis and acid-labile properties of these Schiff bases.
• To assess the anticonvulsant activity of the synthesized compounds in mouse seizure models.

Main Methods:

• Synthesis of 3-aminophenylphosphonic acid derivatives and a benzophenone derivative of GABA.
• Formation of Schiff bases by incorporating these analogues.
• In vitro hydrolysis studies of Schiff bases to determine C=N bond lability.
• Anticonvulsant activity testing using maximal electroshock and pentylenetetrazol-induced seizures in mice.

Main Results:

• Four Schiff bases were synthesized, including novel phosphonodiamide derivatives.
• Hydrolysis studies revealed that ring substituents influence the lability of the C=N bond.
• Anticonvulsant activity was observed only in the maximal electroshock seizure model.
• Moderate inhibition of seizures was demonstrated by specific dimethyl ester and GABA Schiff base derivatives.

Conclusions:

• Novel GABA analogues integrated into Schiff bases show potential as acid-labile carriers.
• The electronic properties of substituents significantly impact the hydrolysis rate of the Schiff base linkage.
• These compounds exhibit moderate anticonvulsant properties, warranting further investigation for epilepsy treatment.